Neoadjuvant Immunochemotherapy for LAOSCC

Conditions: Oral Squamous Cell Carcinoma; Locally Advanced Head and Neck Carcinoma Interventions: Drug: albumin paclitaxel, cispatin, tirellizumab Sponsors: Lai-ping Zhong; Sun Yat-sen University; Fudan University; Central South University; Fujian Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials